Funder: Advanced Research Projects Agency for Health
Due Dates (Anticipated): July 2027 (Solution Summary) | September 2027 (Stage 2, Topics 1–4, 6–7) | October 2027 (Stage 2, Topic 5)
Funding Amounts: Phase 1: up to $600,000, typically 12 months; Phase 2: up to $3.5 million, typically 2–3 years
Summary: SBIR and STTR contracts support small businesses developing transformative health technologies and advancing them toward commercialization.
Key Information: All work must be performed in the United States, and awards depend on ambitious technical and commercialization milestones.
Description
The Advanced Research Projects Agency for Health (ARPA-H) Small Business Program funds innovative health research and development through Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards. The program emphasizes high-impact technologies, ambitious milestones, and a credible path to commercialization rather than incremental advances. Awards are contracts, not grants, and performers work closely with ARPA-H program managers.
The solicitation covers seven topic areas spanning fertility testing, bioadhesives, engineered microbial platforms, endometriosis treatment, autoimmune diagnostics, neurosurgical robotics, and commercialization of technologies originating in ARPA-H-funded work. Projects are scoped for small businesses and favor technologies with shorter development and commercialization timelines than traditional ARPA-H programs. Alongside funding, performers may receive expert guidance, technical resources, and connections to partners, collaborators, and investors.
